Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- BMS Settles Plavix Allegations for Pennies; Ex-CEO Dolan Vindicated (Slightly)
- Bristol-Myers Squibb will pay $2.1 million to settle FTC allegations it made false statements regarding its deal over bloodthinner Plavix with Apotex, according to the WSJ. The news means that BMS has settled all its regulatory troubles over Plavix with the FTC and the states for a...
- Blog posts 2009-03-27
- BMS's Bodnar Caught in His Own Lies on Apotex-Plavix Deal
- Former Bristol-Myers Squibb svp/strategy Andrew Bodnar faces a year in prison after he pled guilty to lying to the FTC about BMS's generic deal with Apotex. The conviction carries a lesson for senior drug company executives hoping to put one over on the government: If you're going...
- Blog posts 2009-04-07
Additional Resources
- Apotex Announces Agreement to Settle U.S. PLAVIX® Litigation; Apotex Announces Agreement to Settle U.S. Plavix® Litigation with Sanofi-aventis and Bristol-Myers Squibb Subject to Certain Conditions
- WESTON, Fla. -- Apotex Inc. and Apotex Corp. announced today that they have reached an agreement with Sanofi-aventis and Bristol-Myers Squibb, subject to certain conditions, to settle the patent infringement lawsuit pending between the parties in the U.S. District Court for the Southern District of New York. The lawsuit relates...
- Research articles 2006-03-22
- U.S. Federal Circuit Court Affirms Judgment for Allergan, Inc. and Roche Palo Alto, LLC against Apotex, Inc., Apotex Corp., and Novex Pharma in Ketorolac Patent Infringement Lawsuit
- IRVINE, Calif. -- Allergan, Inc. (NYSE:AGN) announced today that the United States Court of Appeals for the Federal Circuit has affirmed a favorable ruling for Allergan and Roche Palo Alto, LLC, formerly known as Syntex (U.S.A.) LLC, in a patent infringement lawsuit against Apotex, Inc., Apotex Corp., and Novex Pharma...
- Research articles 2007-04-12
- Apotex Victory in Generic Paxil Confirmed; Federal Circuit Court of Appeals Affirms District Court's Judgment in Favor of Apotex
- Business Editors/Health/Medical Writers WESTON, Fla.--BUSINESS WIRE--April 26, 2004 Apotex Corp. today praised the decision of the U.S. Court of Appeals for the Federal Circuit holding that GSK's U.S. Patent No. 4,721,723, the patent covering PaxilR paroxetine hydrochloride, is invalid. "We feel vindicated with this decision," said Apotex...
- Research articles 2004-04-26
- Apotex, GlaxoSmithKline In Generics Battle Over Paxil.(patent dispute)(Brief Article)
- IN A GENERICS battle in the antidepressant market, Apotex Corp. is seeking an injunction against GlaxoSmithKline GSK and the Food and Drug Administration FDA over its bid to launch a generic version of Paxil paroxetine, GSK's top-selling anti IN A GENERICS battle in the...
- Research articles 2001-05-21
- District Court Denies Apotex's Request to Block Teva's Introduction of First Generic Pravachol® In The U.S.; Court Grants Stay of FDA Approval until after Close of Business Friday
- JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the District of Columbia has denied Apotex's motion for a temporary restraining order and preliminary injunction relating to Apotex's challenge to Teva's 180 days of marketing exclusivity for the first generic version of Bristol-Myers...
- Research articles 2006-04-19
- McIntire gears Apotex for U.S. push
- Tammy McIntire was named president of Apotex Corp. in 1999 after she was recruited by Toronto-based Apotex Inc., a 25-year-old privately held Canadian pharmaceutical manufacturer to head its newly formed U.S. operations in Weston, Fla. McIntire said the driving forces behind her decision were "warmer weather, different climate and...
- Research articles 2000-10-30
- Welsh & Katz Client, Apotex, Inc., Prevails as U.S. Supreme Court Turns Down Pfizer's Request for a Writ of Certiorari
- Court's Decision Means Ruling on Obviousness Remains Precedential in Pfizer, Inc. v. Apotex, Inc.
- Research articles 2007-10-01
- Welsh & Katz Successfully Represents Apotex, Inc. in Federal Circuit Court Decision Against Daiichi
- Appeals Court Reverses Decision in Ofloxacin Patent Case CHICAGO -- The U.S. Court of Appeals for the Federal Circuit issued a decision on July 11, 2007 that Daiichi Sankyo Co.'s patent (U.S. Patent No. 5,401,741) covering a method for treating bacterial ear infections by topically administering the antibiotic ofloxacin...
- Research articles 2007-07-12
- Plavix litigation settlement agreement amended.
- Sanofi- Aventis (Paris, France) and Bristol- Myers Squibb (New York, NY) and Apotex, Inc. and Apotex Corporation (Toronto, Canada) announced that in response to concerns raised by the Federal Trade Commission ("FTC") and state attorneys general to the previously announced proposed settlement the companies reached with...
- Research articles 2006-06-01
- FDA seeks time to answer Paxil charge
- The FDA has asked for more time to respond to a 2/00 Apotex petition that asked the agency to admit improper listing of two new SmithKline Beecham patents on Paxil paroxerine, Apotex lead attorney Hugh Moore (Lord, Bissell & Brook, Chicago) told Dickinson's FDA Webview (www.fdaweb.com) in August. Apotex sued...
- Research articles 2000-10-01
- Unigene and Upsher-Smith File Patent Infringement Lawsuit against Canadian Drug Manufacturer
- FAIRFIELD, N.J. -- Unigene Laboratories, Inc. (OTCBB: UGNE) and Upsher-Smith Laboratories, Inc. have jointly filed in the U.S. District Court for the Southern District of New York a patent infringement lawsuit against Apotex Inc., a Canadian generic pharmaceutical manufacturer, and Apotex Corp., its U.S. subsidiary. The suit was brought in...
- Research articles 2006-07-25
- PFIZER INC - Court Ruling.
- Pfizer Wins Norvasc Patent Challenge by Generic Manufacturer Apotex NEW YORK, Jan. 18 -- Pfizer Inc said today that a federal court in the Northern District of Illinois Chicago has upheld the company's U.S. patent covering amlodipine bes ...
- Research articles 2006-01-18
- Allergan Granted Temporary Restraining Order in ACULAR® Patent Infringement Case
- IRVINE, Calif. -- Allergan, Inc. (NYSE:AGN) announced today that on December 29, 2005, in its patent infringement lawsuit against Apotex, Inc., Apotex Corp., and Novex Pharma (collectively the "Defendants"), the United District Court for the Northern District of California granted Allergan's and Syntex USA LLC's application for a temporary restraining...
- Research articles 2006-01-04
- Fitch Places Bristol-Myers Squibb's Ratings on Rating Watch Negative
- CHICAGO -- Fitch Ratings places Bristol-Myers Squibb's (Bristol-Myers) 'A+' issuer default, senior unsecured debt, and bank loan ratings, and 'F1' commercial paper rating on Rating Watch Negative. The ratings apply to approximately $8.43 billion of outstanding debt. The rating action follows Apotex Inc.'s Apotex announcement of its launch of a...
- Research articles 2006-08-08
- Sanofi. (Active Pharmaceutical Ingredient Watch).(Brief Article)
- SANOFI -Synthelabo Inc. has filed a complaint in a federal district court against Apotex Inc. and Apotex Corp. alleging patent infringement over Plavix clopidogrel bisulfate. UBS Warburg predicts litigation resolution by mid-2004. UBS Warburg estimates globally developed sales with marketing partner Bristol-Myers Squibb Company for Plavix...
- Research articles 2002-04-01
- Sanofi-Aventis slashes share earnings forecast for 2006
- PARIS AFP — French pharmaceutical group Sanofi-Aventis has slashed its 2006 earnings per share forecast from 12 percent to just two percent due to competition for its blockbuster blood-thinner Plavix from a generic drug. The revision came a day after a New York court granted the company and its US...
- Research articles 2006-09-01
- US court upholds patent for heart drug Plavix
- NEW YORK AFP — A US judge on Tuesday upheld the patent for Plavix by French group Sanofi-Aventis and its US partner Bristol-Myers Squibb, blocking a generic version of the blockbuster heart drug. The ruling by US District Judge Sidney Stein bars Canadian firm Apotex from producing a generic...
- Research articles 2007-06-19
- Kroner suit aims to overturn deal on generic form of Plavix
- CINCINNATI -- Kroger Co. has gone to court to block a deal that would delay generic alternatives to the popular blood-thinning drug Plavix. Bristol-Myers Squibb Co. and Sanofi-Aventis had reached a settlement with generic drug maker Apotex Inc. over a patent dispute regarding Plavix, which is the world's No....
- Research articles 2006-04-24
- << Previous
- page 1 of 1
- Next >>
